Rapalogix raises $20m for longevity skin health

Series A funding will expand Re-Q and advance a pipeline built on mTOR biology as longevity science seeks commercial traction. Rapalogix Health has raised $20 million in Series A financing to support the expansion of its longevity-focused skin health platform, as investors continue to back companies…

View Post on Scour ↗

More from longevity.technology on Scour.